Atomoxetine is the generic name for the prescription medication Strattera [1]. It is used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents, and adults [1].
How does atomoxetine work for ADHD?
Atomoxetine is a non-stimulant medication that works by increasing the levels of norepinephrine, a neurotransmitter, in the brain [1]. Norepinephrine plays a role in attention and impulse control, and by affecting its levels, atomoxetine helps to manage ADHD symptoms [1].
When did the patent for Strattera expire?
The original patent for Strattera expired in 2017 [2]. This expiry allowed for the introduction of generic versions of the drug to the market.
What other drugs are used to treat ADHD?
ADHD is commonly treated with stimulant medications, such as methylphenidate (Ritalin, Concerta) and amphetamines (Adderall, Vyvanse) [3]. Atomoxetine (Strattera) is a non-stimulant alternative [1]. Other non-stimulant options may also be available depending on individual needs and physician recommendations.
What are the side effects of atomoxetine?
Common side effects of atomoxetine can include upset stomach, nausea, decreased appetite, dizziness, fatigue, and mood swings [1]. More serious, though less common, side effects can include liver problems, increased heart rate or blood pressure, and suicidal thoughts or behaviors, especially in children and adolescents [1].
Can children take atomoxetine?
Yes, atomoxetine is approved for the treatment of ADHD in children aged 6 years and older, as well as in adolescents and adults [1].
What is the difference between brand-name Strattera and generic atomoxetine?
Generic atomoxetine contains the same active ingredient as brand-name Strattera and is considered therapeutically equivalent [4]. The primary difference is typically in the inactive ingredients, which do not affect the drug's safety or efficacy [4]. Generic medications are usually less expensive than their brand-name counterparts.
Where can I find more information about atomoxetine patents?
Information regarding drug patents, including those for atomoxetine, can often be found through resources like DrugPatentWatch.com [2].
Sources
1. Atomoxetine - National Library of Medicine - DailyMed
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?drugid=19419
2. DrugPatentWatch.com
https://drugpatentwatch.com/
3. National Institute of Mental Health (NIMH) - What Are the Treatments for ADHD?
https://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd/adhd-treatments
4. FDA Basics: Generic Drugs
https://www.fda.gov/drugs/generic-drugs/fda-basics-generic-drugs